title: Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with severity of rheumatoid arthritis in the Czech population.
abstract: Rheumatoid arthritis (RA) is a model of multigenic inflammatory disorder in which tumor necrosis factor-alpha (TNF-alpha) plays an important role. Genetic factors may be implicated in the susceptibility to disease initiation as well as in severity of disease course. Elevated levels of TNF-alpha in the plasma and synovial fluid from RA patients may be associated with polymorphisms in the promoter region of the TNF-alpha gene. The aim of this study was to elucidate putative association between the -308 G/A polymorphism in the promoter region of the TNF-alpha gene and susceptibility to onset and severity of RA. A total of 130 RA patients and a control group of 150 healthy subjects with similar age and sex distribution were available for the study. All patients fulfilled the American College of Rheumatology revised criteria for RA. RA patients had a disease duration of at least 2 years. Radiographs of both hands of all RA patients were scored with the Steinbrocker method. There were 15 patients of stage I (nonerosive form) of RA and 114 patients of stages II-IV (erosive form). To assess the RA patient's functional ability, the Health Assessment Questionnaire (HAQ) was used. The -308 G/A promoter polymorphism of the TNF-alpha gene was detected by polymerase chain reaction and restriction fragment length polymorphism analysis. No differences in genotype distribution and allelic frequences of -308 G/A TNF-alpha promoter polymorphism have been found between RA patients and the control group. Significant differences have been observed within the RA group divided according to the radiographic progression of disease based on the Steinbrocker radiographic score and functional ability (HAQ). These results suggest an association of the -308 G/A polymorphism of the TNF-alpha gene with the severity of RA.
authors.affiliation: Rheumatology Division, 2nd Department of Internal Medicine, St. Anne's University Hospital, Pekarská 53, 656 91, Brno, Czech Republic. petr.nemec@fnusa.cz
authors.forename: Petr
authors.initials: P
authors.lastname: Nemec
authors.forename: Monika
authors.initials: M
authors.lastname: Pavkova-Goldbergova
authors.forename: Martina
authors.initials: M
authors.lastname: Stouracova
authors.forename: Anna
authors.initials: A
authors.lastname: Vasku
authors.forename: Miroslav
authors.initials: M
authors.lastname: Soucek
authors.forename: Jindra
authors.initials: J
authors.lastname: Gatterova
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000175:diagnosis / Q000235:genetics*; D018153:Czech Republic; D005260:Female; D005787:Gene Frequency; D005819:Genetic Markers; D006304:Health Status; D006801:Humans; D008297:Male; D008875:Middle Aged; D012150:Polymorphism, Restriction Fragment Length; D011401:Promoter Regions, Genetic; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D013582:Synovial Fluid / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics* / Q000378:metabolism
chemical_list: D005819:Genetic Markers; D014409:Tumor Necrosis Factor-alpha